CX 2022 Programme
Showing the latest CX 2022 Programme, items subject to change.
If you have any questions concerning the scientific programme, please contact us at [email protected]
All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter timings if necessary.
Vascular Access Masterclass - Wednesday, 27th April
Venue: Richmond
Time: 08:00 - 18:00
Challenges in VA - Creation. Removing Barriers, Increasing Options
08:00 - 10:00
Time: 08:00 - 09:00
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
08:00 - 08:05
Vein preservation - hope or reality?
Speaker: | Jeremy Crane, London, United Kingdom |
08:05 - 08:10
Audience participation and discussion
08:10 - 08:15
Access creation and the heart - pre-op considerations
Speaker: | Joris Rotmans, Leiden, Netherlands |
08:15 - 08:20
Audience participation and discussion
08:20 - 08:25
Making veins bigger
Speaker: | John Lucas III, Greenwood, United States |
08:25 - 08:30
Audience participation and discussion
08:30 - 08:35
Making veins bigger
Speaker: | Surendra Shenoy, St. Louis, United States |
08:35 - 08:40
Audience participation and discussion
08:40 - 08:45
Mapping for all options
Speaker: | Jennifer Hanko, Belfast, United Kingdom |
08:45 - 08:50
Audience participation and discussion
08:50 - 08:55
Are we ignoring other options? The snuff box and the gracz
Speaker: | Robert Shahverdyan, Hamburg, Germany |
08:55 - 09:00
Audience participation and discussion
09:00 - 09:05
An app for access decision making
Speaker: | Karen Stevenson, Glasgow, United Kingdom |
09:05 - 09:10
Audience participation and discussion
New Technologies, New Sites
Time: 09:10 - 10:00
Chairing: | Nicholas Inston, United Kingdom |
Moderators: | Panagiotis Kitrou, Patras, Greece |
Ounali Jaffer, United Kingdom |
09:10 - 09:20
Edited case: Not just creating an endovascular AV fistula, making a difference
Speaker: | Tobias Steinke, Germany |
09:20 - 09:30
Audience participation and discussion
09:30 - 09:35
AVF creation: Comparing surgical and percutaneous outcomes
Speaker: | Alexandros Mallios, Paris, France |
09:35 - 09:40
Audience participation and discussion
09:40 - 09:45
An alternative to open, surgical AV fistula creation
Speaker: | Simon Hogan, London, United Kingdom |
09:45 - 09:50
Audience participation and discussion
09:50 - 09:55
The right access, in the right patient, at the right time, for the right reasons: our experience
Speaker: | Emma Aitken, Glasgow, United Kingdom |
09:55 - 10:00
Audience participation and discussion
Coffee - Networking Break
10:00-10:30
Time: 10:00 - 10:30
Satellite Symposium
Time: 10:00 - 10:30
Challenges in VA Maturation
10:30 - 12:30
Time: 10:30 - 11:30
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
10:30 - 10:35
What have we learnt from device created fistulas about maturation?
Speaker: | Alexandros Mallios, Paris, France |
10:35 - 10:40
Audience participation and discussion
10:40 - 10:45
Is maturation defined by the cannulation? The challenges of device created fistulas
Speaker: | Tobias Steinke, Dusseldorf, Germany |
10:45 - 10:50
Audience participation and discussion
10:50 - 10:55
Podium First: Endovascular salvage of failing AV fistulas utilising sirolimus eluting balloons - 12-month results from the ISABELLA trial
Speaker: | Tjun Tang, Singapore, Singapore |
10:55 - 11:00
Audience participation and discussion
11:00 - 11:05
Pharmacological strategies to improve maturation - novel
Speaker: | Sanjay Misra, Pueblo, United States |
11:05 - 11:10
Audience participation and discussion
11:10 - 11:15
Mechanical adjuncts for creation of more usable fistulas
Speaker: | John Lucas III, Greenwood, United States |
11:15 - 11:20
Audience participation and discussion
11:20 - 11:25
Balloon assisted maturation - BAM! Can radiology improve maturation?
Speaker: | Samuel Walker, Birmingham, United Kingdom |
11:25 - 11:30
Audience participation and discussion
Challenges in VA Maintenance
Time: 11:30 - 12:10
11:30 - 11:35
Wearable technology and access monitoring
Speaker: | Rajesh Sivaprakasam, London, United Kingdom |
11:35 - 11:40
Audience participation and discussion
11:40 - 11:45
Optimising functional patency in AVG - what treatment and when? Results from a retrospective study
Speaker: | David Kingsmore, Glasgow, United Kingdom |
11:45 - 11:50
Audience participation and discussion
11:50 - 11:55
When to intervene - Is 50% the right number?
Speaker: | Ounali Jaffer, Walton on Thames, United Kingdom |
11:55 - 12:00
Audience participation and discussion
12:00 - 12:05
Plain balloon first? Drug-eluting balloon second?
Speaker: | Kate Steiner, Stevenage, United Kingdom |
12:05 - 12:10
Audience participation and discussion
Challenges in VA Salvage
Time: 12:10 - 12:30
12:10 - 12:15
In favour of avoiding unnecessary treatment by a reactive thrombectomy service
Speaker: | Robert Jones, Birmingham, United Kingdom |
12:15 - 12:20
Audience participation and discussion
12:20 - 12:25
In favour of avoiding thrombectomy by earlier intervention
Speaker: | David Kingsmore, Glasgow, United Kingdom |
12:25 - 12:30
Audience participation and discussion
Lunch Break
12:30-13:30
Time: 12:30 - 13:30
Satellite Symposium
Time: 12:30 - 13:00
Cases
13:30 - 15:30
Time: 13:30 - 13:50
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
Managing the Thoracic Outlet in Vascular Access
Time: 13:30 - 13:50
13:30 - 13:35
Diagnosing thoracic outlet syndrome in vascular access
Speaker: | Narayan Karunanithy, London, United Kingdom |
13:35 - 13:40
Audience participation and discussion
13:40 - 13:45
Treating thoracic outlet syndrome in vascular access - IR
Speaker: | Robert Jones, Birmingham, United Kingdom |
13:45 - 13:50
Audience participation and discussion
Masterclass
Time: 13:50 - 14:30
Moderators: | Nicholas Inston, Birmingham, United Kingdom |
Domenico Valenti, London, United Kingdom |
CX Masterclass - Non Dialysis Vascular Access
Time: 13:50 - 14:30
13:50 - 13:55
Vascular access hyperlipidaemia and therapeutic apheresis
Speaker: | David van Dellen, Manchester, United Kingdom |
13:55 - 14:00
Audience participation and discussion
14:00 - 14:05
Vascular access and haemorrhagic and thrombotic disorders
Speaker: | Lara Roberts, London, United Kingdom |
14:05 - 14:10
Audience participation and discussion
14:10 - 14:15
Vascular access and sickle cell disease
Speaker: | Sara Stuart-Smith, United Kingdom |
14:15 - 14:20
Audience participation and discussion
14:20 - 14:25
Vascular access and neurological diseases
Speaker: | Fiona Norwood, London, United Kingdom |
14:25 - 14:30
Audience participation and discussion
New Approaches, New Devices; New Evidence
Time: 14:30 - 15:30
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
14:30 - 14:35
Podium First: The IN.PACT AV Access Study: Results through 36 months
Speaker: | Andrew Holden, Auckland, New Zealand |
14:35 - 14:40
Audience participation and discussion
14:40 - 14:45
Edited case: Endovascular AV fistula creation
Speaker: | Robert Shahverdyan, Hamburg, Germany |
14:45 - 14:50
Audience participation and discussion
14:50 - 14:55
The FACT study
Speaker: | John Lucas III, Greenwood, United States |
14:55 - 15:00
Audience participation and discussion
15:00 - 15:05
AVF creation: Long-term evidence to date
Speaker: | Jeffrey Hull, Midlothian, United States |
15:05 - 15:10
Audience participation and discussion
15:10 - 15:15
Treating challenging AVF lesions in the cephalic arch: What does the data tell us?
Speaker: | Tobias Steinke, Dusseldorf, Germany |
15:15 - 15:20
Audience participation and discussion
15:20 - 15:25
Results from the first-in-man WRAPSODY FIRST study
Speaker: | James Gilbert, Oxford, United Kingdom |
15:25 - 15:30
Audience participation and discussion
Tea - Networking Break
15:30-16:00
Time: 15:30 - 16:00
New Approaches, New Devices, New Evidence continued
16:00 - 18:00
Time: 16:00 - 17:00
Chairing: | Nicholas Inston, Birmingham, United Kingdom |
Moderator: | Domenico Valenti, London, United Kingdom |
16:00 - 16:05
A device for end stage vascular access
Speaker: | Gurkan Sengoelge, Vienna, Austria |
16:05 - 16:10
Audience participation and discussion
16:10 - 16:15
Long-term effectiveness of stent graft treatment of vascular access. Results from the TRESTAR Registry
Speaker: | Matteo Tozzi, Varese, Italy |
16:15 - 16:20
Audience participation and discussion
16:20 - 16:25
Reducing flow, maintaining access - how I do it
Speaker: | Robert Shahverdyan, Hamburg, Germany |
16:25 - 16:30
Audience participation and discussion
16:30 - 16:35
The DEVA study
Speaker: | Robert Jones, Birmingham, United Kingdom |
16:35 - 16:40
Audience participation and discussion
16:40 - 16:45
Improving cannulation, early results
Speaker: | Shawn Gage, Raleigh, United States |
16:45 - 16:50
Audience participation and discussion
16:50 - 16:55
AXESS study: With a new graft
Speaker: | Matteo Tozzi, Varese, Italy |
16:55 - 17:00
Audience participation and discussion
Case Studies in Access - live audience interactive multidisciplinary discussion
Time: 17:00 - 18:00
17:00 - 17:05
Case 1: When lines don’t work
Speaker: | Robert Jones, Birmingham, United Kingdom |
17:05 - 17:10
Audience participation and discussion
17:10 - 17:15
Case 2: non maturing endovascular AVF
Speaker: | Robert Shahverdyan, Hamburg, Germany |
17:15 - 17:20
Audience participation and discussion
17:20 - 17:25
Case 3: perforator stenosis in a percutaneous AVF
Speaker: | Alexandros Mallios, Paris, France |
17:25 - 17:30
Audience participation and discussion
17:30 - 17:35
Haemodialysis vascular access in the elderly patients
Speaker: | Nicholas Inston, United Kingdom |
17:35 - 17:45
Audience participation and discussion
Satellite: Vascular Therapies
Late Breaking Trial
Time: 17:45 - 18:00
17:45 - 17:55
Pharmacological strategies to improve maturation - sirolimus
Speaker: | Rajesh Sivaprakasam, London, United Kingdom |
17:55 - 18:00
Audience participation and discussion